Psychosis Research Today is a free monthly online journal that collates and summarizes the latest research about Psychosis, including details on clinical depression, schizophrenia, bipolar disorder.

Volume 1 (2005), Issue 4 (May)

1. Predominant role of the 9-hydroxy metabolite of risperidone in elevating blood prolactin levels.
   Am J Psychiatry, 162(5): 1010-2. [Abstract] [Full-text]
2. Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial.
   Am J Psychiatry, 162(5): 947-53. [Abstract] [Full-text]
3. Migration, family dysfunction and psychotic symptoms in children and adolescents.
   Br J Psychiatry, 186: 442-3. [Abstract] [Full-text]
4. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction.
   Biol Psychiatry, 57(10): 1117-27. [Abstract] [Full-text]
5. Cognitive functions in prepsychotic patients.
   Prog Neuropsychopharmacol Biol Psychiatry, 29(4): 621-5. [Abstract] [Full-text]
6. Patients with very-late-onset schizophrenia-like psychosis: a follow-up study.
   Am J Geriatr Psychiatry, 13(5): 417-9. [Abstract] [Full-text]
7. Socioeconomic status of origin and the clinical expression of Schizophrenia.
   Schizophr Res, 75(2): 417-24. [Abstract] [Full-text]
8. The psychotic spectrum: validity and reliability of the Structured Clinical Interview for the Psychotic Spectrum.
   Schizophr Res, 75(2): 375-87. [Abstract] [Full-text]
9. Hippocampal and anterior cingulate morphology in subjects at ultra-high-risk for psychosis: the role of family history of psychotic illness.
   Schizophr Res, 75(2): 295-301. [Abstract] [Full-text]
10. Hippocampus and amygdala volumes in schizophrenia and other psychoses in the Northern Finland 1966 birth cohort.
    Schizophr Res, 75(2): 283-94. [Abstract] [Full-text]
11. The course and clinical correlates of dysfunctions in visual perceptual organization in schizophrenia during the remission of psychotic symptoms.
    Schizophr Res, 75(2): 183-92. [Abstract] [Full-text]
12. Is unawareness of psychotic disorder a neurocognitive or psychological defensiveness problem?
    Schizophr Res, 75(2): 147-57. [Abstract] [Full-text]
13. Extrapyramidal symptoms and signs in first-episode, antipsychotic exposed and non-exposed patients with schizophrenia or related psychotic illness.
    J Psychopharmacol, 19(3): 277-85. [Abstract] [Full-text]
14. Lithium concentration correlates with QTc in patients with psychosis.
    J Electrocardiol, 38(2): 148-51. [Abstract] [Full-text]
15. Comparisons between psychosis samples with different patterns of substance use recruited for clinical and epidemiological studies.
    Psychiatry Res, 134(3): 241-50. [Abstract] [Full-text]
16. Sexual health knowledge and risk behaviour in young people with first episode psychosis.
    Int J Ment Health Nurs, 14(2): 149-54. [Abstract] [Full-text]
17. Cognitive behaviour therapy within acute mental health care: a critical appraisal.
    Int J Ment Health Nurs, 14(2): 96-102. [Abstract] [Full-text]
18. Relation of surgery, tumor site, and age group to the loss of reality testing in Japanese patients with malignant tumors: a study of a hospital-based sample with a consultation-liaison service.
    Psychiatry Clin Neurosci, 59(3): 259-65. [Abstract] [Full-text]
19. Visual feedback therapy to enhance medication adherence in psychosis.
    Arch Psychiatr Nurs, 19(2): 70-80. [Abstract] [Full-text]
20. Epidemiology of first- and second-generation antipsychotic agents in Lombardy, Italy.
    Pharmacopsychiatry, 38(3): 128-31. [Abstract] [Full-text]
21. Reasons for switching between antipsychotics in daily clinical practice.
    Pharmacopsychiatry, 38(3): 122-4. [Abstract] [Full-text]
22. Psychotic symptoms in the general population of England--a comparison of ethnic groups (The EMPIRIC study).
    Soc Psychiatry Psychiatr Epidemiol, 40(5): 375-81. [Abstract] [Full-text]
23. The impact of family experience on the duration of untreated psychosis (DUP) in Hong Kong.
    Soc Psychiatry Psychiatr Epidemiol, 40(5): 350-6. [Abstract] [Full-text]
24. Duration of untreated psychotic illness: the role of premorbid social support networks.
    Soc Psychiatry Psychiatr Epidemiol, 40(5): 345-9. [Abstract] [Full-text]
25. A community intervention for early identification of first episode psychosis: impact on duration of untreated psychosis (DUP) and patient characteristics.
    Soc Psychiatry Psychiatr Epidemiol, 40(5): 337-44. [Abstract] [Full-text]
26. Subjective distress related to side effects and subjective well-being in first admitted adolescents with early-onset psychosis treated with atypical antipsychotics.
    J Child Adolesc Psychopharmacol, 15(2): 249-58. [Abstract] [Full-text]
27. The impact of cognitive and psychiatric impairment of psychotic disorders on the test of memory malingering (TOMM).
    Assessment, 12(2): 123-9. [Abstract] [Full-text]
28. Self-reported psychotic symptoms predict impulsivity among African-American patients in an urban non-psychiatric medical setting.
    Psychiatry Res, 135(1): 35-44. [Abstract] [Full-text]

© 2005-2008 Psychosis Research Today. All Rights Reserved.